Focused on biotechnology research and development, the company works on therapies derived from genetic and molecular science aimed at treating complex diseases. Its value to investors is largely tied to the progress of its clinical pipeline, regulatory milestones, and potential partnerships with lar...
No congressional trades have been disclosed for Gena Corporation (GN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.